CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy PI3 Kinase Inhibitors Serine-Threonine Kinase Inhibitors Epigenetics Kinase Inhibitors Tyrosine Kinase Inhibitors Chemotherapy EGFR Other | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Diffuse Large B Cell Lymphoma | Cervical Cancer | Colorectal Cancer | Chronic Lymphocytic Leukemia | Lung Cancer | Follicular Lymphoma | Marginal Zone Lymphoma | Triple Negative Breast Cancer |
---|---|---|---|---|---|---|---|---|---|---|
durvalumab + tremelimumab | ||||||||||
ibrutinib | ||||||||||
anlotinib + sintilimab | ||||||||||
Immunotherapy | ||||||||||
cyclophosphamide + epirubicin | ||||||||||
PD1 inhibitor | ||||||||||
zanubrutinib | ||||||||||
decitabine | ||||||||||
chidamide | ||||||||||
ibrutinib + chidamide | ||||||||||
ibrutinib + decitabine | ||||||||||
afatinib + SHP099 | ||||||||||
R-CHOP |